The United Kingdom [NHS Cervical Screening Programmes (CSPs)](#bib24){ref-type="other"} have reduced the incidence of, and mortality from, cervical cancer ([Quinn *et al*, 1999](#bib33){ref-type="other"}; [Sasieni and Adams, 1999](#bib35){ref-type="other"}). However, the screening test has a high degree of sensitivity, resulting, each year, in over 250 000 cervical smears showing abnormalities ([NHS Cervical Screening Programmes, 2003](#bib23){ref-type="other"}; [NHS Scotland, Information and Statistics Division, 2004](#bib26){ref-type="other"}). For women, receipt of an abnormal smear test result frequently leads to heightened levels of anxiety ([Bell *et al*, 1995](#bib2){ref-type="other"}; [Gath *et al*, 1995](#bib11){ref-type="other"}; [Maissi *et al*, 2004](#bib19){ref-type="other"}). Women who have received an abnormal smear result have reported frequent worries and feeling worse about their body ([Lerman *et al*, 1991](#bib18){ref-type="other"}; [Wardle *et al*, 1995](#bib43){ref-type="other"}). Often an abnormal smear result leads to a fear on the part of the woman that she has cancer ([Doherty *et al*, 1991](#bib7){ref-type="other"}; [Lerman *et al*, 1991](#bib18){ref-type="other"}; [Somerset and Peters, 1998](#bib38){ref-type="other"}) and to feelings of self-blame, sexual guilt and concerns about infertility ([McDonald *et al*, 1989](#bib22){ref-type="other"}; [Quilliam, 1990](#bib32){ref-type="other"}; [Kavanagh and Broom, 1997](#bib17){ref-type="other"}).

The overwhelming majority of abnormal smears detected each year are low-grade (i.e. borderline nuclear abnormalities (BNA) or mild dyskaryosis). Most previous research on the psychosocial impact of an abnormal smear has focussed on women with high-grade abnormal smears (i.e. those showing moderate or severe dyskaryosis) and has tended to recruit women attending for a colposcopic examination, making it difficult to separate the psychosocial sequelae of the smear test result itself from the well-documented procedural distress arising from colposcopy ([Posner and Vessey, 1988](#bib31){ref-type="other"}; [Marteau *et al*, 1990](#bib21){ref-type="other"}). It might be expected that psychosocial effects may differ according to the severity of the smear abnormality, and the management strategy adopted. Few studies of the effects of abnormal smear results have included low-grade abnormalities. Moreover, the available studies have been limited in terms of size, by a lack of distinction between different grades of abnormality, or by confounding by management/follow-up ([Bell *et al*, 1995](#bib2){ref-type="other"}; [Maissi *et al*, 2004](#bib19){ref-type="other"}). Thus, the factors associated with adverse psychosocial sequelae among women with low-grade abnormal smears have not been well elucidated.

This paper focuses on the psychological and psychosocial effects associated with receipt of a low-grade abnormal smear test result. Over 3500 women participated in the study, all of whom were recruited into the TOMBOLA trial (Trial Of Management of Borderline and Other Low-grade Abnormal smears), a pragmatic randomised controlled trial of management policies for women with low-grade abnormal smears ([Sharp, 2002](#bib37){ref-type="other"}). The aims of the study were to: (1) quantify the levels of anxiety and depression associated with having received a low-grade abnormal smear result, (2) identify factors associated with increased levels of anxiety, and (3) identify whether the psychosocial impact of the abnormal smear result is higher in particular subgroups of women (for example, defined by age, smear result grade and prior history of another low-grade abnormal smear).

MATERIALS AND METHODS
=====================

Subjects
--------

A total of 3731 TOMBOLA participants recruited between February 2001 and January 2003 took part in the detailed psychosocial evaluations. Eligible women were aged 20--59 years, had had a smear (termed the index smear) taken routinely as part of the NHS CSPs that showed a low-grade abnormality (either mild dyskaryosis or BNA), had no more than one BNA smear in the previous three years, and were resident in the Grampian Health Board area, Tayside Health Board area or in the Nottingham area. Women were ineligible if they were pregnant at the time of recruitment or had had previous destructive or excisional treatment for proven or suspected cervical lesions. Recruitment to TOMBOLA consisted of sending an information leaflet together with an appointment to attend a hospital-based recruitment clinic to eligible women. Women eligible for psychosocial evaluations, who had provided informed consent, were asked to complete a socio-demographic and lifestyle questionnaire and a baseline psychosocial assessment.

Materials/measures
------------------

The socio-demographic and lifestyle questionnaire collected information including ethnic group, marital status, education since leaving school, employment status, pregnancy and childbirth, smoking habits and physical activity. Information on time from index smear to recruitment was obtained from the trial database. The baseline psychosocial booklet included the Hospital Anxiety and Depression Scale (HADS) ([Zigmond and Snaith, 1983](#bib45){ref-type="other"}), the Multi-dimensional Health Locus of Control Scale (MHLCS) ([Wallston *et al*, 1978](#bib42){ref-type="other"}) and a questionnaire designed specifically for use within TOMBOLA, the Process Outcome Specific Measure (POSM) ([Gray *et al*, 2005](#bib13){ref-type="other"}).

The HADS is a well-validated instrument used to screen for clinically significant depression and anxiety. It is a self-report inventory that consists of 14 items on two subscales, seven items measuring anxiety and seven measuring depression. Each item is scored on a four-point scale from 0 to 3. The items are summed yielding two subscale scores each ranging from 0 to 21. Following established practice, we categorised women\'s scores to indicate 'non-cases\' (scores 0--7), 'possible cases\' (scores 8--10) and 'probable cases\' (scores of 11 or more) ([Fayers and Machin, 2000](#bib8){ref-type="other"}). Most women (*n*=3530) completed all of the questions on the HADS. For those who had completed at least 50% of either the anxiety or depression subscales (*n*=35 (\<1%); *n*=31 (\<1%), respectively), best subset regression ([StataCorp, 2003](#bib39){ref-type="other"}) was used to impute scores. The remaining women were excluded from the analyses.

The MHLCS measures three dimensions of health locus of control: 'internality\'; 'chance externality\'; and 'powerful others externality\' ([Wallston *et al*, 1978](#bib42){ref-type="other"}). The scale consists of three six-item subscales, scored using a six-point forced choice response scale, which ranges from 1 'strongly disagree\' to 6 'strongly agree\'. Possible scores on each subscale range from 6 to 36. As recommended by the MHLCS authors, a score was calculated for respondents who had completed at least four out of six questions for each subscale ([Wallston, 2004](#bib41){ref-type="other"}). For the internal subscale 109 (3%) women had scores imputed. For the powerful others subscale 152 (4%) women had scores imputed and for the chance subscale 170 (5%) women had scores imputed. Women who failed to complete at least four questions on a subscale were excluded from the analysis: *n*=79 (2%) for the internal subscale, *n*=80 (2%) for the powerful others subscale, and *n*=91 (3%) for the chance subscale.

The POSM consists of 16 questions, 11 of which are framed in the form of forced choice personalised statements using a six-point Likert style response format ranging from 'strongly agree\' to 'strongly disagree\', and two that relate to change and include a no change response option ([Gray *et al*, 2005](#bib13){ref-type="other"}). There are two filter questions, which allow respondents to skip questions not applicable to them. There is one question that asks about perceived risk of developing cervical cancer in the future. The POSM was included in the analysis to help identify factors likely to be particularly relevant to the management of low-grade abnormalities, which may be associated with raised levels of anxiety. Levels of missing data did not exceed 4% for any one question.

Analysis
--------

Univariate analysis using the *χ*^2^-test was used to investigate associations between anxiety and socio-demographic factors, depression, POSM and MHLCS. Owing to the very small proportion of women scoring ⩾11 on the HADS depression subscale, all scores of 8 or more on this subscale were combined into one category (possible and probable cases combined). The MHLCS subscale scores were divided into tertiles. The responses to the POSM were combined to produce either a dichotomous outcome (i.e. agree/disagree) or three-point response outcomes (e.g. change for the better/no change/change for the worse).

Factors associated with anxiety were investigated using multiple logistic regression to compute odds ratios (OR) using STATA 8.0 ([StataCorp, 2003](#bib39){ref-type="other"}). The binary outcome variable was \<8 and ⩾8. This categorisation was chosen because (1) the aim of interventions to minimise or reduce anxiety would be to render subjects 'non-cases\' (i.e. to have a score of less than 8 on the anxiety subscale), and (2) the three-point categorisation would not have permitted stable estimates to be obtained from the multivariate analysis. A range of socio-demographic and lifestyle factors, the HADS depression subscale, the three dimensions of the MHLCS and all of the 14 informative questions of the POSM were considered as potential explanatory variables. A multivariate model was developed using a nested approach; if the *P*-value for the likelihood ratio test of the change in deviance (−2 × log likelihood) between a model containing a particular variable, and a model not containing this variable, was less than 0.1, the variable was retained in the model. The goodness-of-fit of each model was checked using the Hosmer & Lemeshow test ([Hosmer and Lemeshow, 1989](#bib14){ref-type="other"}) and the final model reported fits the data adequately (*P*=0.666).

RESULTS
=======

Of the 3731 women who attended a recruitment appointment and consented to participate in the TOMBOLA psychosocial study, 3671 (98%) completed both a socio-demographic and psychosocial questionnaire.

The mean age of participants was 34 (standard deviation (s.d.)=10.6 years). Forty-two per cent of women were in the 20--29 year age group ([Table 1](#tbl1){ref-type="table"}). Twent-four per cent were recruited on the basis of a mild smear and 76% on the basis of a BNA smear. 5% of women had had a BNA smear in the three years before the index smear: 24 of these women had a mild index smear and 155 a smear showing BNA. The median time from index smear to recruitment (and hence completion of the questionnaires) was 71 days. Ninety-six per cent of women described their ethnic group as white. Slightly more than half were married or living as married (56%) and half were in full-time employment (50%). Slightly more women had been to college/university (54%) than had not (47%). Almost half of the women reported that they had never smoked, 35% that they were current smokers and 17% that they were ex-smokers.

Over half of the women (57%) were classed as being a non-case (scored \<8 on the HADS anxiety subscale). A fifth of women had scores consistent with being possible cases (scored 8--10) and almost a quarter (23%) had scores that indicated a probable clinically significant level of anxiety (scored ⩾11). The vast majority of women (91%) were classed as non-cases on the HADS depression subscale (scored \<8). The mean MHLCS score for the internal subscale was 26 (s.d. 4.3). For the powerful others subscale the mean score was 17 (s.d. 5.9) and for the chance subscale the mean score was 19 (s.d. 5.3).

In univariate analyses, statistically significant associations were found between anxiety and age, trial centre, marital status, employment status, training, physical activity, ever having had a child, and smoking status ([Table 2](#tbl2){ref-type="table"}). The associations with age, physical activity, ever having had a child and smoking status remained in the multivariate analysis. A lower proportion of older women (aged 50--59) scored 8--10 or ⩾11 on the HADS anxiety subscale than women in other age groups (*χ*^2^=16.89, *P*=0.010). When those scoring ⩾8 on the HADS anxiety subscale were combined, the multivariate OR for the 50--59 *vs* the 20--29 age groups was statistically significantly less than unity (OR=0.68, 95% confidence interval (CI)=0.48--0.97). Women exercising \>3 times per week were more likely to be classed as probable cases (26%) or possible cases (22%) than women who took exercise less than once per week or took no exercise (22% probable cases and 19% possible cases). The multivariate risk estimate for the most active group *vs* the least active was statistically significantly raised (OR=1.52, 95% CI=1.26--1.85). Women who had had children were significantly more likely to be anxious than women who never had children (OR=1.26, 95% CI=1.03--1.55). This was accounted for by an increased proportion scoring ⩾11 among those having had children. 29% of current smokers were classified as probable cases compared to 22% of ex-smokers and 19% of never smokers. The OR for current smokers was significantly higher than unity (OR=1.52, 95% CI=1.26--1.84). There was little evidence of an association between anxiety and either index smear status or previous history of a BNA smear ([Table 2](#tbl2){ref-type="table"}). The time between a woman\'s index smear test and date of completion of the psychosocial questionnaire (recruitment date) was not related to HADS anxiety score (data not shown).

There was a very strong association between the HADS anxiety and the HADS depression scores. Ninety-five per cent of women who scored ⩾8 on the depression subscale also scored ⩾8 on the anxiety subscale ([Table 3](#tbl3){ref-type="table"}). The strength of the association was reflected in the OR of 29.14 (95% CI=16.22--52.37). In the univariate analyses, there were significant associations between all three locus of control subscales and anxiety status. However, the association with the chance subscale did not persist in the multivariate analysis. Risk of anxiety decreased with increasing score on the internal subscale (*P* for trend=0.008).

In the univariate analysis there were statistically significant associations between anxiety and all but three of the POSM questions -- these questions related to (1) whether the information received answered concerns about the smear result (question 2), (2) future cervical screening intentions (question 13), and (3) belief about regular screening reducing the risk for cervical cancer (question 14). In the multivariate analysis, there were significant associations between anxiety and worries about general health, feelings about self, worries about cervical cancer, future fertility, sex life, perceived risk of cervical cancer and support. Cases of anxiety were more common among women who felt worse about themselves since receiving their smear result (OR=2.07, 95% CI=1.70--2.53). There were very strong positive relations between anxiety and worries that the next smear would show changes to the cells, worries about having cervical cancer, worries about future fertility and worries about having sex. Fifty per cent of women reporting that their sex life had changed for the worse were probable cases compared to 19% reporting no change and 25% reporting change for the better.

DISCUSSION
==========

We found that 23% of women who had recently received a low-grade abnormal cervical smear test result scored ⩾11 on the anxiety subscale of the HADS, and a further 20% scored between 8 and 10. The frequency scoring ⩾11 was substantially higher than that observed in women in a non-clinical general adult UK population (16%) ([Crawford *et al*, 2001](#bib4){ref-type="other"}). Moreover, our findings are consistent with those from a study of women who had received higher-grade abnormal cervical smear results ([Bell *et al*, 1995](#bib2){ref-type="other"}).

Age was inversely associated with anxiety in our final model (*P*=0.031), although the risk estimate was only statistically significant for women in the oldest age group (50--59 years). It may be that older women had fewer worries about issues such as future fertility and their sex lives and thus, were not as concerned by the smear result. Screening uptake in the UK exceeds 80% ([NHS CSP, 2004](#bib24){ref-type="other"}; [ISD Scotland, 2005](#bib27){ref-type="other"}) and the frequency of low-grade abnormal smears is highest in women under 30 and declines with age (10.5% of smears in this age group, compared to 5.7, 4.7 and 2.8% in the 30--39, 40--49 and 50--59 age groups, respectively) ([NHS Health and Social Care Information Centre, 2005](#bib25){ref-type="other"}). The implication of our results is that considerable numbers of younger women could be experiencing adverse psychosocial consequences of screening. At the time participants were recruited to the study, the NHS CSPs in England and Scotland screened women aged 20--59 (Scotland) or 64 (England). Since then, and in response to analyses suggesting that smears are not as effective in younger women ([Sasieni *et al*, 2003](#bib36){ref-type="other"}), the programme in England has raised the lower screening limit to 25 (<http://www.cancerscreening.nhs.uk/cervical>). This age limit is consistent with programmes in countries including Norway, Italy, France and Belgium, although is still younger than the lower age limit in some other countries (e.g. Finland, Sweden, Netherlands) ([IARC Working Group, 2005](#bib16){ref-type="other"}). It might be suggested that the levels of anxiety experienced by younger women with low-grade smears provides a further argument for excluding these women from screening. It is noteworthy, however, that in our analysis the risk of having a HADS anxiety score of ⩾8 was essentially the same in women aged 30--39 as those aged 20--29 (multivariate OR 30--39 *vs* 20--29=0.97). Moreover, 26% of the 30--39 age group were classified as definite cases (score ⩾11) compared to 23% of the 20--29 age group. Thus, our observation of an inverse association between age and anxiety is not simply a consequence of higher levels in the youngest women; there are considerable levels of anxiety in women aged 30--39 and this needs to be addressed.

A mild smear corresponds to a higher grade of abnormality than a BNA smear; however, there was no relation between smear status and HADS anxiety score. There are at least two possible explanations for this. First, before their TOMBOLA recruitment appointment, women may not have been told explicitly what their smear result was. We are aware that women may not be told the grade of their smear result, but simply that it is abnormal. This is supported by a study from a single health authority (Nottingham), which showed that there was considerable variation in both the method and content of communications delivering mild and BNA smear results ([Philips *et al*, 2002](#bib30){ref-type="other"}). Second, women may have been told the grade of the smear but may not have understood its clinical significance. For example, a BNA smear may have been interpreted as being 'borderline cancer\' rather than 'borderline normal\'. It appears that women often do not understand the purpose and indications of the cervical smear ([Fylan, 1998](#bib10){ref-type="other"}), or the meaning of pre-cancer, and erroneously conclude that any abnormalities detected by screening must indicate cancer ([Kavanagh and Broom, 1997](#bib17){ref-type="other"}). As our results indicate that there are similar levels of anxiety overall among women with low-grade smears as among women with high-grade smears, it seems likely that it is the receipt of an abnormal smear result *per se*, irrespective of the grade, which engenders adverse psychosocial consequences. We anticipated that women who had had a BNA smear result in the three years before their index smear would be more anxious than women who had not previously had an abnormal smear. However, there was no relationship between prior BNA smear and anxiety. In part this may have been due to the relatively small numbers of women in our study who had had a prior BNA smear (*n*=175, 5% overall). Alternatively, it is possible that receipt of an abnormal smear causes a spike in anxiety that resolves over time, thus a smear taken up to 3 years ago might not impact on current anxiety levels. A recent study showed that whereas informing women that they had an abnormal smear (with or without HPV testing) was associated with raised levels of state anxiety and general distress in the first month following receipt of results, this was no longer evident 6 months later ([Maissi *et al*, 2005](#bib20){ref-type="other"}).

Elucidation of factors associated with raised levels of anxiety is likely to be helpful in identifying: (1) particularly vulnerable subgroups of the population, (2) particular issues that may be causing concern or worries among women, and (3) targets that could be addressed in interventions aimed at helping alleviate anxiety. Having had children was a significant predictor of scoring ⩾8 on the HADS anxiety subscale. Previous studies have shown that there are higher rates of psychiatric disorders in women with children, although the authors of these studies have suggested that the difference is due to an effect of marriage rather than parity ([Dean and White, 1996](#bib6){ref-type="other"}). In our study, marital status was significantly associated with having had children; over 70% of women who were married/living as married (or who had previously been married) had had children compared to only 19% of single women. Marital status, however, was not associated with anxiety in our multivariate model.

Women who reported themselves to be current smokers were significantly more likely to be anxious than women who had never smoked. Other studies have found an association between smoking and increased anxiety, and poor psychological health has been shown to increase cigarette consumption ([Graham and Der, 1999](#bib12){ref-type="other"}; [Bonnet *et al*, 2005](#bib3){ref-type="other"}). One possible explanation for our finding could be that smokers believe that smoking raises their cervical cancer risk. In our study, women who thought that their chances of getting cancer were higher than average were at increased risk of being anxious and smoking status was significantly associated with belief about chance of getting cancer. Twenty per cent of current smokers believed their chance was higher than average, 74% that it was average and 7% that it was less than average; the comparable figures for never smokers were 18, 71 and 12%.

We found that women who were most physically active were significantly more likely to score ⩾8 on the HADS anxiety subscale. An explanation for this intriguing finding is not obvious, and we might have expected the opposite relation given the positive effects of exercise on endorphins, and hence on mental health generally ([Daley, 2002](#bib5){ref-type="other"}). Although the difficulties in accurate assessment of physical activity levels in epidemiological studies are well known ([IARC Working Group, 2002](#bib15){ref-type="other"}), there is no evidence that reporting varies by level of anxiety. It is possible that women who engage in the highest levels of physical activity are also the most health conscious and, as a result, are most anxious when they receive an abnormal smear result.

Women who were worried about their general health, that their next smear would be abnormal or about having cervical cancer were all at a significantly increased risk of being anxious compared to women who were not worried about these issues. This is consistent with other studies in which receipt of an abnormal smear is associated with women\'s fears that they have cancer ([Doherty *et al*, 1991](#bib7){ref-type="other"}; [Lerman *et al*, 1991](#bib18){ref-type="other"}; [Somerset and Peters, 1998](#bib38){ref-type="other"}). Women who perceived their chances of developing cervical cancer in the future to be higher than average were at a significantly increased risk of being anxious than women who perceived their chances as average or below average. This is congruent with a recent study of women who had received inadequate smear results among whom perceived risk was found to be a risk factor for state anxiety ([French *et al*, 2004](#bib9){ref-type="other"}). In the current study, anxiety was significantly higher in women who were worried about their ability to have children in the future and in those who had decided to delay getting pregnant. Previous studies have confirmed that women who have had an abnormal smear are concerned about their future fertility and that this may be related to fear about what further treatment might be involved ([McDonald *et al*, 1989](#bib22){ref-type="other"}; [Quilliam, 1990](#bib32){ref-type="other"}).

Two of the POSM questions asked about change in self-perception and change in sex life since receipt of the smear test result. Interestingly, women who indicated any change, whether for the better or for the worse, were more likely to be anxious than women who responded that there had been no change. It may be that the change (for better or for worse) resulted from increased anxiety caused by the abnormal smear result.

Although most of the responses to the POSM questions were associated with anxiety in multivariate analyses, five were not. Two of these questions related to intention to continue having regular smears and belief that regular smears reduce risk of developing cervical cancer. For both of these questions, only small proportions of women (\<1 and 3%, respectively) disagreed with the statements. It might have been expected, given the reasonably high overall levels of anxiety in the study population, that women might have felt somehow dissatisfied with the information they had received about their smear result. In contrast, over 90% of women felt well informed about what their smear result meant and 92% were satisfied that the information received had addressed any concerns. This apparent contradiction may suggest that the information that women receive (or source for themselves), and/or the way in which the information is conveyed, is not providing adequate reassurance. Previous research has shown that the way in which smear results are conveyed and the content of the communication varies, not only across, but also within health authorities ([Philips *et al*, 2002](#bib30){ref-type="other"}). Moreover, there is no guarantee that women will understand the information contained in the communication of the smear result. Further study of what information women receive and how different methods of communicating results to women influence levels of anxiety would be useful.

We observed a significant inverse relationship between internal locus of control and anxiety and, compatible with this, women who scored highly on the powerful others externality subscale were at increased risk of anxiety. Other studies have found that an external locus of control is significantly associated with anxiety disorders and that women who score highly on the internal subscale are more likely to report good health ([Raja *et al*, 1994](#bib34){ref-type="other"}; [Beekman *et al*, 2000](#bib1){ref-type="other"}). In relation to communication and information provision, a recent study found that matching health messages to an individual\'s health locus of control in women resulted in higher attendance for a mammogram ([Williams-Piehota *et al*, 2004](#bib44){ref-type="other"}). It may be possible to assess locus of control in the context of cervical screening and to present information that is targeted to match the individual\'s locus of control, for example, when women access web-based health information.

We assessed anxiety using the HADS, a screening (rather than diagnostic) test for clinically significant anxiety (and depression) which is widely used in both clinical and non-clinical settings ([Crawford *et al*, 2001](#bib4){ref-type="other"}; [Strik *et al*, 2004](#bib40){ref-type="other"}). Although we were not in a position to cross validate the HADS cut-offs for possible and probable cases with a standardised diagnostic interview, in pilot testing the HADS proved reliable in women recruited to TOMBOLA ([Gray *et al*, 2005](#bib13){ref-type="other"}). In terms of classifying respondents, investigators have used a variety of schemes, including cut-offs at 8 ([Osborne *et al*, 2003](#bib28){ref-type="other"}) and 11 ([Pascoe *et al*, 2000](#bib29){ref-type="other"}). We decided to take a score of ⩾8 as indicating a level of anxiety that could be considered abnormal and, therefore, may warrant intervention. The main reason for choosing 8 as a cut-off was that we wanted to ensure that any suggested interventions arising from the analyses would be relevant to the greatest number of women (i.e. not just to women scoring above 10). The aim of such interventions would be to render the maximum number of women 'non-cases\' (i.e. to have a score of less than 8 on the anxiety subscale); thus, it would not be sufficient to move women who were probable cases to possible cases. A secondary consideration was that we wanted the estimates from our multivariate analyses to be stable making sure that we had an adequate number of subjects in each analysis cell/subgroup: using a cut-off of 8, rather than 11, helped to ensure this. We undertook a sensitivity analysis to determine whether our results were dependent on the chosen cut-point. The analysis was repeated using a score of 11 or more to identify 'cases\' with those scoring 10 or less classified as 'non-cases\'. The results were essentially unchanged; the only substantive difference was that level of post-school education entered the model as a significant predictor of anxiety.

Strengths and limitations of the study
--------------------------------------

Our study is one of the very few to have focussed only on women with low-grade abnormal smears. As far as we are aware, it is the largest study of the psychological status of women with such abnormalities and, including more than 3500 women, it is one of the largest studies of the determinants of anxiety to have been reported.

Participants were recruited from the cervical screening programmes in Scotland and England and are likely to be representative of the UK screening population as a whole. The three study centres comprise both rural and city-based populations and incorporate affluent and deprived areas and the centre in England was ethnically diverse. Ninety-eight per cent of women asked to complete the psychosocial questionnaires did so. Furthermore, we measured anxiety prior to women knowing how they would be followed-up so there is no contamination of the results with any effects of treatment. Women in TOMBOLA are being followed for 3 years, over which time they will complete psychosocial questionnaires at four time points. This will permit temporal trends in anxiety to be charted.

Women were asked to complete the questionnaires at a recruitment appointment in a hospital-based clinic setting and it is possible that attending the appointment contributed to anxiety. [Maissi *et al*, 2004](#bib19){ref-type="other"} found that whether an abnormal smear is a woman\'s first smear may be a predictor of concern about the test result. Our access to a woman\'s smear history before her participation in TOMBOLA was restricted. Therefore, we could not identify whether the abnormal smear that made a woman eligible for inclusion in TOMBOLA was her first cervical smear. However, the lack of a substantial difference in anxiety between women aged 20--29 and women aged 30--39 suggests that our results are not driven by the effect of first smears. Twenty-one per cent of women aged 20--29 scored between 8 and 10 compared to 20% of women aged 30--39; furthermore, 23% of women aged 20--29 scored ⩾11 compared to 26% of women aged 30--39. Although standardised trial information leaflets were given to all participants, women received their smear results in the usual way and this differed between and within centres. We also had no control over the information women received from other health professionals or sourced for themselves. This undoubtedly led to variation in the amount and quality of information women received and also in the means of communication.

Implications and conclusions
----------------------------

Assessing the levels and determinants of psychological and psychosocial consequences of receiving a low-grade abnormal smear result is of considerable public health importance. As low-grade smears account for the majority of cervical smears classed as abnormal in the UK, the results of our study suggest that significant numbers of women could be incurring adverse psychological and psychosocial consequences of screening. We have found a high prevalence of anxiety among women who have a low-grade smear, and that the proportion scoring in the abnormal range is consistent with previous studies of women with high-grade smear results. We further found that those who are at highest risk of anxiety tend to be younger, have children, be current smokers, or have higher levels of physical activity. These may represent particularly vulnerable subgroups of the screening population. We will further investigate the determinants of anxiety in the analysis of the TOMBOLA longitudinal data. Strategies are needed to minimise the adverse effects of a low-grade smear result on women. Interventions that focus particularly on women\'s understanding of smear results and pre-cancer, and those that directly address their fears about cancer, treatment and fertility might provide greatest opportunity to reduce the adverse psychosocial impact of receiving a low-grade abnormal cervical smear result.
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Figures and Tables
==================

###### 

Socio-demographic characteristics of respondents participating in the baseline psychological assessment within TOMBOLA

                                                                ***n***   **%**
  ------------------------------------------------------------ --------- -------
  *Age group*                                                            
   20--29 years                                                  1551      42
   30--39 years                                                   982      27
   40--49 years                                                   797      22
   50--59 years                                                   341       9
                                                                             
  *Index smear status*                                                   
   Mild                                                           882      24
   BNA                                                           2789      76
                                                                             
  *Previous smear history in the 3 years before index smear*             
   No abnormal smear                                             3492      95
   One BNA                                                        179       5
                                                                             
  *Trial centre*                                                         
   A                                                             1207      33
   B                                                              882      24
   C                                                             1582      43
                                                                             
  *Ethnic group*                                                         
   White                                                         3515      96
   Non-white                                                      148       4
   Missing                                                         8       ---
                                                                             
  *Marital status*                                                       
   Married/living as married                                     2042      56
   Divorced/separated/widowed                                     492      14
   Single                                                        1107      30
   Missing                                                        30       ---
                                                                             
  *Employment status*                                                    
   Full-time paid employment                                     1819      50
   Part-time paid employment                                      864      24
   Student                                                        340       9
   Not in paid employment                                         645      18
   Missing                                                         3       ---
                                                                             
  *Training*                                                             
   None                                                           990      27
   Through work with qualification                                725      20
   Qualification other than degree from college/university       1046      29
   Degree from college/university                                 901      25
   Missing                                                         9       ---
                                                                             
  *Physical activity*                                                    
   \<Once/week                                                   1456      40
   1--3 times/week                                                867      24
   \>3 times/week                                                1310      36
   Missing                                                        38       ---
                                                                             
  *Ever had children*                                                    
   Yes                                                           2048      56
   No                                                            1591      44
   Missing                                                        32       ---
                                                                             
  *Smoking status*                                                       
   Never smoker                                                  1760      48
   Ex-smoker                                                      627      17
   Current smoker                                                1260      35
   Missing                                                        24       ---

###### 

Associations between the HADS anxiety subscale and socio-demographic and lifestyle factors

  **Hospital Anxiety and Depression Scale -- anxiety subscale**                                                            
  --------------------------------------------------------------- ------ ---- ----- ---- ----- ------------- ------------- ------------
  *Age group*                                                                                                              
   20--29 years                                                    850    57   308   21   341       23           1.00         (ref)
   30--39 years                                                    516    54   189   20   253       26           0.97       0.78--1.22
   40--49 years                                                    456    59   154   20   169       22           0.85       0.66--1.10
   50--59 years                                                    211    65   60    18   55        17           0.68       0.48--0.97
   *P*-value from *χ*^2^-test                                                                    **0.010**                       
   *P*-value from *χ*^2^-test for trend                                                                        **0.031**         
   Global *P*-value                                                                                              0.133           
                                                                                                                                 
  *Index smear status*                                                                                                     
   Mild                                                            477    56   161   19   213       25           1.00         (ref)
   BNA                                                             1556   57   550   20   605       22           1.09       0.90--1.32
   *P*-value from *χ*^2^-test                                                                      0.236                         
   Global *P*-value                                                                                              0.397           
                                                                                                                                 
  *Previous smear history in the 3 years before index smear*                                                               
   No abnormal smear                                               1930   57   675   20   782       23           1.00         (ref)
   One BNA                                                         103    59   36    21   36        21           0.93       0.64--1.37
   *P*-value from *χ*^2^-test                                                                      0.742                         
   Global *P*-value                                                                                              0.722           
                                                                                                                                 
  Median time from index smear to recruitment (days)                72         70         70                                     
                                                                                                                                 
  *Trial centre*                                                                                                           
   A                                                               707    61   237   20   214       18           1.00         (ref)
   B                                                               470    54   169   19   231       27           1.06       0.85--1.33
   C                                                               856    56   305   20   373       24           0.95       0.79--1.16
   *P*-value from *χ*^2^-test                                                                   **\<0.001**                      
   Global *P*-value from LR test                                                                                 0.595           
                                                                                                                                 
  *Ethnic group*                                                                                                           
   White                                                           1955   57   671   20   788       23           1.00         (ref)
   Non-white                                                        78    56   35    25   27        19           0.80       0.51--1.25
   *P*-value from *χ*^2^-test                                                                      0.242                         
   Global *P*-value from LR test                                                                                 0.324           
                                                                                                                                 
  *Marital status*                                                                                                         
   Married/living as married                                       1155   58   368   19   464       23           1.00         (ref)
   Divorced/separated/widowed                                      251    53   99    21   124       26           0.98       0.76--1.28
   Single                                                          610    57   240   22   222       21           0.90       0.71--1.13
   *P*-value from *χ*^2^-test                                                                    **0.019**                       
   Global *P*-value from LR test                                                                                 0.638           
                                                                                                                                 
  *Employment status*                                                                                                      
   Full-time paid employment                                       1075   60   349   20   355       20           1.00         (ref)
   Part-time paid employment                                       483    57   172   20   186       22           0.97       0.77--1.21
   Student                                                         175    55   72    23   72        23           1.04       0.77--1.40
   Not in paid employment                                          298    48   118   19   204       33           1.02       0.79--1.33
   *P*-value from *χ*^2^-test                                                                   **\<0.001**                      
   Global *P*-value from LR test                                                                                 0.970           
                                                                                                                                 
  *Training*                                                                                                               
   None                                                            522    54   180   19   258       27           1.00         (ref)
   Through work with qualification                                 378    54   150   21   176       25           1.14       0.89--1.45
   Qualification other than degree from college/university         616    60   190   19   214       21           0.84       0.67--1.06
   Degree from college/university                                  512    59   190   22   167       19           0.97       0.75--1.25
   *P*-value from *χ*^2^-test                                                                    **0.001**                       
   Global *P*-value from LR test                                                                                 0.096           
                                                                                                                                 
  *Physical activity*                                                                                                      
   \<Once/week                                                     838    60   263   19   304       22           1.00         (ref)
   1--3 times/week                                                 509    60   159   19   181       21           1.13       0.91--1.40
   \>3 times/week                                                  663    52   283   22   324       26           1.52       1.26--1.85
   *P*-value from *χ*^2^-test                                                                    **0.001**                       
   *P*-value from *χ*^2^-test for trend                                                                       **\<0.001**        
   Global *P*-value from LR test                                                                              **\<0.001**        
                                                                                                                                 
  *Ever had children*                                                                                                      
   No                                                              931    60   307   20   311       20           1.00         (ref)
   Yes                                                             1085   55   401   20   497       25           1.26       1.03--1.55
   *P*-value from *χ*^2^-test                                                                    **0.001**                       
   Global *P*-value from LR test                                                                               **0.025**         
                                                                                                                                 
  *Smoking status*                                                                                                         
   Never smoker                                                    1070   63   320   19   319       19           1.00         (ref)
   Ex-smoker                                                       350    58   123   20   132       22           1.22       0.97--1.54
   Current smoker                                                  603    49   262   21   360       29           1.52       1.26--1.84
   *P*-value from *χ*^2^-test                                                                   **\<0.001**                      
   Global *P*-value from LR test                                                                              **\<0.001**        

Outcome either 0=non-cases (\<8) or 1=definite or doubtful cases (=\>8).

Mutually adjusted for: ever had children, training, smoking status, physical activity, age, depression, internal subscale, powerful others subscale, POSM q3--6, q10, q11, q15, q16. 139 women did not complete a sufficient number of questions on one or more of the outcome measures and were excluded from the analysis.

Bold values indicate statistically significant results.

###### 

Associations between the HADS anxiety subscale and the HADS depression subscale status, baseline MHLCS status and POSM responses

  **Hospital Anxiety and Depression Scale -- anxiety subscale**                                                                                                                
  ------------------------------------------------------------------------------------------------------------------- ------ ---- ----- ---- ----- ------------- ------------- --------------
  *Depression subscale*                                                                                                                                                        
   Non-case (\<8)                                                                                                      2017   62   659   20   566       17           1.00          (ref)
   Doubtful/probable case (8 or more)                                                                                   15    5    51    16   251       79           29.14      16.22--52.37
   *P*-value from *χ*^2^-test                                                                                                                       **\<0.001**                       
   Global *P*-value from LR test                                                                                                                                  **\<0.001**         
                                                                                                                                                                                      
  *MHLCS internal (tertiles)*                                                                                                                                                  
   Low                                                                                                                 580    53   225   20   294       27           1.00          (ref)
   Medium                                                                                                              592    58   203   20   221       22           0.87        0.70--1.07
   High                                                                                                                834    59   278   20   295       21           0.76        0.63--0.93
   *P*-value from *χ*^2^-test                                                                                                                        **0.004**                        
   *P*-value from *χ*^2^-test for trend                                                                                                                            **0.008**          
   Global *P*-value from LR test                                                                                                                                   **0.030**          
                                                                                                                                                                                      
  *MHLCS chance (tertiles)*                                                                                                                                                    
   Low                                                                                                                 697    62   195   17   234       21           1.00          (ref)
   Medium                                                                                                              557    58   196   20   213       22           0.99        0.80--1.23
   High                                                                                                                744    52   315   22   360       25           1.08        0.88--1.33
   *P*-value from *χ*^2^-test                                                                                                                       **\<0.001**                       
   *P*-value from *χ*^2^-test for trend                                                                                                                              0.430            
   Global *P*-value from LR test                                                                                                                                     0.627            
                                                                                                                                                                                      
  *MHLCS powerful others (tertiles)*                                                                                                                                           
   Low                                                                                                                 668    65   178   17   178       17           1.00          (ref)
   Medium                                                                                                              719    60   203   17   267       22           0.96        0.78--1.19
   High                                                                                                                618    47   325   25   365       28           1.55        1.26--1.91
   *P*-value from *χ*^2^-test                                                                                                                       **\<0.001**                       
   *P*-value from *χ*^2^-test for trend                                                                                                                           **\<0.001**         
   Global *P*-value from LR test                                                                                                                                  **\<0.001**         
                                                                                                                                                                                      
  POSM questions                                                                                                                                                               
  *1 In general I feel well enough informed about what my smear result means.*                                                                                                 
   Agree                                                                                                               1835   58   630   20   702       22           1.00          (ref)
   Disagree                                                                                                            184    50   74    20   112       30           1.22        0.93--1.60
   *P*-value from *χ*^2^-test                                                                                                                        **0.001**                        
   Global *P*-value from LR test                                                                                                                                     0.151            
                                                                                                                                                                                      
  *2 The information I have received has answered the concerns I have had about my smear result.*                                                                              
   Agree                                                                                                               1845   57   649   20   731       23           1.00          (ref)
   Disagree                                                                                                            113    50   47    21   65        29           1.24        0.89--1.73
   *P*-value from *χ*^2^-test                                                                                                                          0.067                          
   Global *P*-value from LR test                                                                                                                                     0.208            
                                                                                                                                                                                      
  *3 Since getting my smear result I have been worried about my general health.*                                                                                               
   Disagree                                                                                                            820    77   126   12   118       11           1.00          (ref)
   Agree                                                                                                               1196   48   577   23   697       28           1.83        1.47--2.28
   *P*-value from *χ*^2^-test                                                                                                                       **\<0.001**                       
   Global *P*-value from LR test                                                                                                                                  **\<0.001**         
                                                                                                                                                                                      
  *4 Since getting my smear result the way I feel about myself has changed.*                                                                                                   
   Neither better nor worse                                                                                            1547   67   388   17   370       16           1.00          (ref)
   For the better                                                                                                      140    43   80    25   105       32           1.82        1.37--2.43
   For the worse                                                                                                       322    36   231   26   335       38           2.07        1.70--2.53
   *P*-value from *χ*^2^-test                                                                                                                       **\<0.001**                       
   Global *P*-value from LR test                                                                                                                                  **\<0.001**         
                                                                                                                                                                                      
  *5 Since getting my smear result I have been worried that my next smear will show changes to the cells.*                                                                     
   Disagree                                                                                                            307    80   46    12   29         8           1.00          (ref)
   Agree                                                                                                               1707   54   658   21   783       25           1.48        1.03--2.12
   *P*-value from *χ*^2^-test                                                                                                                       **\<0.001**                       
   Global *P*-value from LR test                                                                                                                                   **0.031**          
                                                                                                                                                                                      
  *6 Since getting my smear result I have been worried that I may have cervical cancer.*                                                                                       
   Disagree                                                                                                            846    75   167   15   121       11           1.00          (ref)
   Agree                                                                                                               1165   49   536   22   691       29           1.50        1.22--1.85
   *P*-value from *χ*^2^-test                                                                                                                       **\<0.001**                       
   Global *P*-value from LR test                                                                                                                                  **\<0.001**         
  *8 Since getting my smear result I have been worried about my ability to have children in the future.*^c^                                                                    
   Disagree                                                                                                            359    71   84    17   66        13           1.00          (ref)
   Agree                                                                                                               362    46   183   23   246       31           1.61        1.19--2.18
   *P*-value from *χ*^2^-test                                                                                                                       **\<0.001**                       
   Global *P*-value from LR test                                                                                                                                   **0.002**          
                                                                                                                                                                                      
  *9 Because of the follow-up for my smear I have decided to delay getting pregnant.*^c^                                                                                       
   Disagree                                                                                                            313    61   104   20   94        18           1.00          (ref)
   Agree                                                                                                                85    39   49    23   83        38           1.41        0.94--2.12
   *P*-value from *χ*^2^-test                                                                                                                       **\<0.001**                       
   Global *P*-value from LR test                                                                                                                                     0.101            
                                                                                                                                                                                      
  *10 Since getting my smear result I have been worried about having sex.*                                                                                                     
   Disagree                                                                                                            1623   65   463   18   429       17           1.00          (ref)
   Agree                                                                                                               348    37   227   24   366       39           1.75        1.44--2.11
   *P*-value from *χ*^2^-test                                                                                                                       **\<0.001**                       
   Global *P*-value from LR test                                                                                                                                  **\<0.001**         
                                                                                                                                                                                      
  *12 Since getting my smear result my sex life has changed.*^d^                                                                                                               
   Neither better nor worse                                                                                            1628   62   500   19   504       19           1.00          (ref)
   For the better                                                                                                       29    43   21    31   17        25           1.38        0.76--2.53
   For the worse                                                                                                        78    28   61    22   141       50           1.50        1.06--2.13
   *P*-value from *χ*^2^-test                                                                                                                       **\<0.001**                       
   Global *P*-value from LR test                                                                                                                                   **0.046**          
                                                                                                                                                                                      
  *13 I intend to continue having regular smears.*                                                                                                                             
   Agree                                                                                                               1998   57   704   20   809       23           1.00          (ref)
   Disagree                                                                                                             8     73    1    9     2        18           1.28        0.31--5.26
   *P*-value from *χ*^2^-test                                                                                                                          0.535                          
   Global *P*-value from LR test                                                                                                                                     0.733            
                                                                                                                                                                                      
  *14 I believe that having regular smears reduces my risk of getting cervical cancer.*                                                                                        
   Agree                                                                                                               1896   57   680   20   775       23           1.00          (ref)
   Disagree                                                                                                             72    62   20    17   25        21           0.86        0.54--1.37
   *P*-value from *χ*^2^-test                                                                                                                          0.545                          
   Global *P*-value from LR test                                                                                                                                     0.516            
                                                                                                                                                                                      
  *15 What do think your chances are of developing cervical cancer in the future?*                                                                                             
   Average                                                                                                             1520   60   478   19   526       21           1.00          (ref)
   Lower than average                                                                                                  210    61   69    20   63        18           0.99        0.74--1.34
   Higher than average                                                                                                 262    41   154   24   217       34           1.71        1.38--2.12
   *P*-value from *χ*^2^-test                                                                                                                       **\<0.001**                       
   Global *P*-value from LR test                                                                                                                                  **\<0.001**         
                                                                                                                                                                                      
  *16 Since getting my smear result I have generally been satisfied with the support I have had from other people.*                                                            
   Agree                                                                                                               1827   58   638   20   705       22           1.00          (ref)
   Disagree                                                                                                            130    44   61    21   103       35           1.56        1.15--2.11
   *P*-value from *χ*^2^-test                                                                                                                       **\<0.001**                       
   Global *P*-value from LR test                                                                                                                                   **0.004**          

Outcome either 0=non cases (\<8) or 1=definite or doubtful cases (=\>8)

Mutually adjusted for: ever had children, training, smoking status, physical activity, age, depression, internal subscale, powerful others subscale, POSM q3--6, q10, q11, q15, q16. 139 women did not complete a sufficient number of questions on one or more of the outcome measures and were excluded from the analysis.

In women who did not answer 'no\' to POSM q7 (Before you received your smear result were you planning to have a child in the future?).

In women who did not answer 'no\' to POSM q11 (Are you sexually active?).

Bold values indicate statistically significant results.
